Stock Report

Rossari Biotech Ltd Q4 FY2024 consolidated net profit at Rs. 34.13 crores

Posted On : 2024-04-29 21:13:13( TIMEZONE : IST )

Rossari Biotech Limited has reported Consolidated financial results for the period ended March 31, 2024.

Financial Results (Q4 FY2024) - QoQ Comparison

The company has reported total income of Rs. 473.105 crores during the period ended March 31, 2024 as compared to Rs. 467.271 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs. 34.132 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 34.390 crores for the period ended December 31, 2023.

The company has reported EPS of Rs. 6.17 for the period ended March 31, 2024 as compared to Rs. 6.21 for the period ended December 31, 2023.

Financials	Q4 FY2024	Q3 FY2024	% Change
Total Income	₹ 473.105 crs	₹467.271 crs	1.25%
Net Profit	₹34.132 crs	₹34.390 crs	-0.75%
EPS	₹6.17	₹6.21	-0.64%

Financial Results (Q4 FY2024) - YoY Comparison

The company has reported total income of Rs. 473.105 crores during the period ended March 31, 2024 as compared to Rs.409.272 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs.34.132 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.28.979 crores for the period ended March 31, 2023.

The company has reported EPS of Rs.6.17 for the period ended March 31, 2024 as compared to Rs.5.24 for the period ended March 31, 2023.

Financials	Q4 FY2024	Q4 FY2023	% Change
Total Income	₹ 473.105 crs	₹409.272 crs	15.60%
Net Profit	₹34.132 crs	₹28.979 crs	17.78%
EPS	₹6.17	₹5.24	17.75%

Financial Results (Year Ended FY2024) - YoY Comparison

The company has reported total income of Rs.1838.004 crores during the Financial Year ended March 31, 2024 as compared to Rs.1661.365 crores during the Financial Year ended March 31, 2023.

The company has posted net profit / (loss) of Rs.130.689 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.107.257 crores for the Financial Year ended March 31, 2023.

The company has reported EPS of Rs.23.62 for the Financial Year ended March 31, 2024 as compared to Rs.19.38 for the Financial Year ended March 31, 2023.

Financials	Year Ended FY2024	Year Ended FY2023	% Change
Total Income	₹1838.004 crs	₹1661.365 crs	10.63%
Net Profit	₹130.689 crs	₹107.257 crs	21.85%
EPS	₹23.62	₹19.38	21.88%

Shares of Rossari Biotech Limited was last trading in BSE at Rs. 769.85 as compared to the previous close of Rs. 762.10. The total number of shares traded during the day was 8050 in over 862 trades.

The stock hit an intraday high of Rs. 774.60 and intraday low of 755.05. The net turnover during the day was Rs. 6164973.00.